Weeks after the Food and Drug Administration approved the Alzheimer's drug Aduhelm, doctors are struggling to figure out who should get the drug and how to use it safely. Image credit: Charles Krupa/AP
Brought to you by: Assistant Edge
Brought to you by: Assistant Edge